Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 32789480

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JAMA Oncol
Publication date
2020 Sep 1
First author
Yu KD

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2021 Mar 1;7(3):461. doi: 10.1001/jamaoncol.2020.7160.
    note
    Source null
    related pmid
    33410871
    relationship
    Comment in
  2. citation
    JAMA Oncol. 2021 Mar 1;7(3):460-461. doi: 10.1001/jamaoncol.2020.7157.
    note
    Source null
    related pmid
    33410889
    relationship
    Comment in

Authors and identifiers

  1. name
    Yu KD
    type
    Author
  2. name
    Ye FG
    type
    Author
  3. name
    He M
    type
    Author
  4. name
    Fan L
    type
    Author
  5. name
    Ma D
    type
    Author
  6. name
    Mo M
    type
    Author
  7. name
    Wu J
    type
    Author
  8. name
    Liu GY
    type
    Author
  9. name
    Di GH
    type
    Author
  10. name
    Zeng XH
    type
    Author
  11. name
    He PQ
    type
    Author
  12. name
    Wu KJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Yu KD
    type
    Author
  2. name
    Ye FG
    type
    Author
  3. name
    He M
    type
    Author
  4. name
    Fan L
    type
    Author
  5. name
    Ma D
    type
    Author
  6. name
    Mo M
    type
    Author
  7. name
    Wu J
    type
    Author
  8. name
    Liu GY
    type
    Author
  9. name
    Di GH
    type
    Author
  10. name
    Zeng XH
    type
    Author
  11. name
    He PQ
    type
    Author
  12. name
    Wu KJ
    type
    Author
bibliography ids
  1. nci-bib-777cf5e2c0183a039676c2a3
book metadata
content sha256
3863351277596382a881ab600150c56829ba1e74a56a0f33bfc179e10f837b92
document type
citation
dois
  1. 10.1001/jamaoncol.2020.2965
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:32789480
immutable id
pubmed:32789480@3863351277596382a881ab600150c56829ba1e74a56a0f33bfc179e10f837b92
journal
abbreviation
JAMA Oncol
issn electronic
2374-2445
issn print
2374-2437
issue
9
name
JAMA oncology
nlm unique id
101652861
pages
1390-1396
volume
6
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    JAMA Oncol. 2021 Mar 1;7(3):461. doi: 10.1001/jamaoncol.2020.7160.
    note
    Source null
    related pmid
    33410871
    relationship
    Comment in
  2. citation
    JAMA Oncol. 2021 Mar 1;7(3):460-461. doi: 10.1001/jamaoncol.2020.7157.
    note
    Source null
    related pmid
    33410889
    relationship
    Comment in
outcomes validated
false
pmid
32789480
provenance
batch id
40d9eae1f1d369f13109
provider
NCBI PubMed ESummary
record sha256
84217c7a5dc3511eff37ce604b1b14b256625a27d6656ef5339379c878dda2c6
response sha256
03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
retrieved at
2026-09-09T23:47:52.637547+00:00
publication date
display
2020 Sep 1
precision
day
year
2020
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/32789480/
title
Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Preserved source evidence · Not medical advice